Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2022-08-30EMA Withdrawn: Pioglitazone Teva Pharma (pioglitazone hydrochloride) — Teva Pharma B.V.
The EMA has withdrawn the pioglitazone hydrochloride product Teva Pharma B.V. from the market.
-
CLINICAL_TRIALS withdrawal · 2022-08-26Clinical Trial Update: Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy [Phase 4]
A Phase 4 clinical trial examining an intervention for high-normal blood pressure in adults with type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-07-27Clinical Trial Update: Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus. [Phase 3]
A Phase 3 clinical trial investigating the efficacy and safety of Lima Association for Type 2 diabetes mellitus was withdrawn.
-
EMA withdrawal · 2022-06-28EMA Withdrawn: Starlix (nateglinide) — Novartis Europharm Limited
EMA withdrew Starlix (nateglinide) from the market for Type 2 diabetes.
-
CLINICAL_TRIALS withdrawal · 2022-02-03Clinical Trial Update: SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating two weekly dose schedules of semaglutide in Type 2 diabetes has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-10-11Clinical Trial Update: Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit [Phase 4]
A Phase 4 clinical trial evaluating metformin and sitagliptin in adults with type 2 diabetes has been withdrawn. No results reported.
-
CLINICAL_TRIALS withdrawal · 2021-10-08Clinical Trial Update: REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations [Phase 4]
A Phase 4 trial evaluating empagliflozin in type 2 diabetes and chronic kidney disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-08-24Clinical Trial Update: A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes [Phase 4]
A Phase 4 trial evaluating a novel basal insulin titration approach (LY2963016) in type 2 diabetes was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-06-10Clinical Trial Update: Effects of DPP4 Inhibition on COVID-19 [Phase 4]
A Phase 4 trial examining the effects of DPP-4 inhibition on COVID-19 has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-03-10Clinical Trial Update: Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease [Phase 3]
Phase 3 trial assessing liraglutide for metabolic profile in type 2 diabetes with cardiovascular disease was withdrawn.
-
EMA withdrawal · 2020-10-09EMA Withdrawn: Qtrilmet (metformin hydrochloride;saxagliptin;dapagliflozin) — AstraZeneca AB
EMA has withdrawn Qtrilmet (metformin hydrochloride; saxagliptin; dapagliflozin) for Type 2 diabetes from AstraZeneca AB.
-
CLINICAL_TRIALS withdrawal · 2020-02-25Clinical Trial Update: Empaglifozin in Early Diabetic Kidney Disease [Phase 3]
Phase 3 trial of empagliflozin in early diabetic kidney disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-01-14Clinical Trial Update: Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes. [Phase 4]
Phase 4 trial comparing ertugliflozin to hydrochlorothiazide for reducing sympathetic neural overactivity in patients with hypertension and …
-
CLINICAL_TRIALS withdrawal · 2019-03-20Clinical Trial Update: Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients [Phase 4]
A Phase 4 trial comparing cardiovascular outcomes of pioglitazone and metformin in type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-03-18Clinical Trial Update: Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes [Phase 4]
A Phase 4 trial investigating prevention of type 2 diabetes after gestational diabetes was withdrawn.
-
EMA withdrawal · 2019-02-20EMA Withdrawn: Eperzan (albiglutide) — GlaxoSmithKline Trading Services Limited
The EMA has withdrawn Eperzan (albiglutide) from the European market.
-
CLINICAL_TRIALS withdrawal · 2019-02-04Clinical Trial Update: Neujia Anastomosis for Treatment of Obesity and Type II Diabetes [NA]
A clinical trial (NCT03675074) assessing Neujia Anastomosis for obesity and Type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 study evaluating pharmacokinetics, safety and efficacy of albiglutide in pediatric patients with type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-16Clinical Trial Update: Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin [Phase 4]
A Phase 4 trial comparing aggressive versus conservative blood glucose control in hospitalized patients with Type 2 diabetes was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-11-14Clinical Trial Update: Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment [Phase 2, Phase 3]
A Phase 2/Phase 3 study evaluating berberine hydrochloride and bifidobacterium for Type 2 diabetes mellitus was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-12Clinical Trial Update: Taking on Diabetes to Advance You (TODAY) [NA]
The clinical trial TODAY (NCT03121508) investigating Type 2 Diabetes Mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-16Clinical Trial Update: Glucotoxicity and Acute Exercise [NA]
The clinical trial NCT01771614 on glucotoxicity and acute exercise in individuals with diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-04-02Clinical Trial Update: Ghrelin and Beta Cell Function in Diabetes [Phase 1]
A Phase 1 trial evaluating ghrelin's effect on beta cell function in Type 2 Diabetes Mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-09Clinical Trial Update: Assessment of a Health Informatics System on Insulin-treated Diabetic Patients
The clinical trial evaluating a health informatics system for insulin-treated patients with type 1 or type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-07Clinical Trial Update: Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals [Phase 3]
A Phase 3 trial testing whether vitamin D supplementation reduces the risk of developing Type 2 Diabetes Mellitus in high-risk individuals h…